Flemington, NJ, United States of America

Edwin A Collier

This inventor holds 1 USPTO granted patent, plus 2 CIPO patents and 1 EPO patent. Top assignee: Janssen Pharmaceutica Nv. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Edwin A Collier. Retrieved from https://idiyas.com/inventor/edwin-a-collier

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0


 

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2015

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Edwin A. Collier: Innovator in Pharmaceutical Co-Crystals

Introduction

Edwin A. Collier is a notable inventor based in Flemington, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of co-crystals that have potential therapeutic applications.

Latest Patents

Collier holds a patent for L-proline and citric acid co-crystals of (2S, 3R, 4R, 5S, 6R)-2-(3-((5-(4-fluorophenyl)thiophen-2-yl)methyl)-4-methylphenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol. This invention is directed towards pharmaceutical compositions containing these co-crystals and their use in treating glucose-related disorders such as Type 2 diabetes mellitus and Syndrome X. He has 1 patent to his name.

Career Highlights

Collier is associated with Janssen Pharmaceutica NV, where he has been involved in innovative research and development. His work focuses on creating effective pharmaceutical solutions that address critical health issues.

Collaborations

Some of his coworkers include Minh Nguyen, who have collaborated with him on various projects within the pharmaceutical sector.

Conclusion

Edwin A. Collier's contributions to the field of pharmaceuticals through his innovative patent on co-crystals highlight his role as a significant inventor. His work continues to impact the treatment of important health conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…